Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook

34°
- Decatur, IN (46733)
  Today
  
  Cloudy. Temps nearly steady in the mid 30s. Winds SW at 15 to 25 mph. Higher wind gusts possible..
  
  Tonight
  
  Cloudy with periods of light rain. Becoming windy late. Low 34F. Winds SSW at 20 to 30 mph. Chance of rain 80%. Winds could occasionally gust over 40 mph.
  
  Updated: December 9, 2025 @ 12:18 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Classifieds
- Place an ad
E-Edition
Best of 2024

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

309.88 +1.35 (+0.44%)

Streaming Delayed Price Updated: 1:13 PM EST, Dec 9, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Bio-Rad to Host Investor Day on February 25

February 02, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022

January 25, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Overview Of Value Stocks In The Healthcare Sector ↗

January 24, 2022

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11

January 05, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Free COVID Tests: What Stocks Will Benefit? ↗

December 23, 2021

The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.

Via Talk Markets

Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President

December 16, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

A Look Into Healthcare Sector Value Stocks ↗

November 01, 2021

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs ↗

October 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...

Via Benzinga

Bio-Rad Laboratories, inc (BIO) Q3 2021 Earnings Call Transcript ↗

October 28, 2021

BIO earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Bio-Rad Reports Third-Quarter 2021 Financial Results

October 28, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug ↗

October 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...

Via Benzinga

Thermo Fisher Stock Strength Rating Climbs To 81; Medical Devices Maker Shows Market Leadership ↗

October 28, 2021

Thermo Fisher Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.

Via Investor's Business Daily

Preview: Bio-Rad Laboratories's Earnings ↗

October 27, 2021

Bio-Rad Laboratories (NYSE:BIO) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

October 25, 2021

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021

October 15, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

Fulgent Genetics Stock Meets 80-Plus Relative Strength Rating Benchmark ↗

October 11, 2021

A Relative Strength Rating upgrade for Fulgent Genetics shows improving technical performance.

Via Investor's Business Daily

15 Under 40, 14 Over 90: A Look At The Youngest And Oldest Members Of The Forbes 400 List ↗

October 09, 2021

The annual Forbes 400 list highlights the people in the United States who have a ...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

September 27, 2021

The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may...

Via Benzinga

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

Medpace Stock Earns Relative Strength Rating Upgrade; Remains In Buy Zone ↗

September 02, 2021

Ohio-based Medpace stock saw its Relative Strength Rating enter the 80-plus level while it stays in a buy zone.

Via Investor's Business Daily

Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference

August 31, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug ↗

August 25, 2021

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
Announcements
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Decatur Daily Democrat

DecaturDailyDemocrat.com
141 S. Second Street
Decatur, IN 46733
Phone: 260-724-2121
Email: reporter@decaturdailydemocrat.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Decatur, IN (46733)

Today

Tonight

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

Sections

Services

Decatur Daily Democrat